TCG Lifesciences Streamlines Processes to Enhance Business Efficiency, Implement Secure Data Management Strategies, and Reduce Costs

This IDC Perspective highlights how TCG Lifesciences (TCGLS) leveraged advanced technologies to enhance operational efficiency and decision making across multiple business functions. By utilizing AI for predictive analysis in retrosynthetic route planning, ML for task automation, and data analytics for actionable insights, TCGLS significantly improved its business intelligence. Robust data management systems ensured the seamless sharing of insights across teams, whereas Druva provided secure backup solutions. The infrastructure, built on Java Enterprise Edition (Java EE) and Java 11, supported seamless integration with client data formats. Additionally, robotic process automation (RPA) powered by UiPath optimized supply chain and finance operations. Barcode integration enabled rapid and accurate sample identification in retrieval and distribution processes.TCGLS' compound management application improved efficiency, collaboration, and knowledge sharing. Key benefits include zero errors in shipping over 100,000 compounds, faster drug discovery, real-time client access, and enhanced product quality while supporting seamless collaboration internally and externally."Invest in GenAI solutions that align with your long-term strategic goals, focusing on super use cases to deliver measurable value. Prioritize high-quality data and robust governance to ensure AI initiatives are ethical and secure. Embrace agentic AI to bridge legacy systems with modern technologies, and cultivate strategic partnerships to leverage diverse expertise for tailored, impactful solutions," says Deepika Giri, AVP, IDC Asia/Pacific.